[Evidentic] Adalimumab

[Evidentic] Adalimumab

 

BATCH NUMBER: 73254XH03

Target

TNF alpha

Class of molecule

Monoclonal Antibody

Isotype

IgG1 - Fully human

Host cells

Chinese Hamster Ovary (CHO) cells

Prepared from (Reference drug)​

Humira®

Therapeutic Area

Auto-immune diseases

Therapeutic Indications

Ankylosing Spondylitis, Crohn's Disease, Juvenile rheumatoid arthritis, Psoriasis, Psoriatic Arthritis, Ulcerative colitis, Uveitis

Mechanism of Action (MoA)

Neutralises the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors

Pharmacotherapeutic group​​

Immunosuppressants

List of Excipients​

Mannitol
Polysorbate 80
Water for injections

Product specifications:​

• Quality Standard

  clinical grade
• Product Concentration

  100 mg/mL
• Volume per vial

  40 µL
• Quantity per vial

  4 mg
• Batch Number

  73254XH03
• Storage Temperature

  -80°C

 

• Original therapeutic expiry date:

  12/2018

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.